News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Conference News ESC 2024 Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events Caitlin E. Cox August 31, 2024
News Daily News Could an App Replace Statin Prescribing by Doctors? Michael O'Riordan September 08, 2021
News Daily News FDA Passes on Inclisiran, Citing Manufacturing Site Problems Shelley Wood December 23, 2020
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Conference News ESC 2019 ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date Yael L. Maxwell September 03, 2019
News Conference News SCCT 2019 Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology Yael L. Maxwell July 15, 2019
News Conference News ACC 2019 Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom Michael O'Riordan March 20, 2019
News Daily News Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering Shelley Wood October 29, 2018
News Daily News Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors Michael O'Riordan June 13, 2018
News Daily News PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations Michael O'Riordan May 10, 2018
News Daily News Top-Line REVEAL Results Support Efficacy of CETP Inhibition, but Questions Abound Todd Neale June 27, 2017
News Daily News Therapies Aimed at New Genetic Target Show Early Promise for Lowering Triglycerides Todd Neale May 26, 2017
News Features Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter Michael O'Riordan January 10, 2017
News Daily News High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds Todd Neale December 19, 2016
News Daily News Judge Dismisses AstraZeneca’s Bid to Block Generic Crestor Shelley Wood July 20, 2016
News Daily News AstraZeneca Strives to Block Generic Crestor as Observers Call Foul Michael O'Riordan July 13, 2016
News Daily News FDA: No Cardiovascular Event Reduction Claim for Ezetimibe Shelley Wood February 16, 2016